
When artificial tears and basic home care are no longer controlling dry, burning, or irritated eyes, it may be time to look at what is actually causing the problem. Advanced dry eye treatment can target inflammation, meibomian gland dysfunction, poor blinking, eyelid laxity, or damage to the ocular surface.
At Morris Eye Associates in Mendham, we offer advanced options including OptiLight, OptiLift, and cryopreserved amniotic membranes. These treatments work differently, so choosing the right one depends on what we find during your dry eye evaluation.
OptiLight is an Intense Pulsed Light treatment designed for dry eye associated with meibomian gland dysfunction. The meibomian glands produce oils that help slow tear evaporation. When these glands become inflamed or do not function properly, tears may disappear too quickly from the eye's surface.
OptiLight delivers controlled pulses of light around the treatment area to help address inflammation and support healthier meibomian gland function.
It may be considered for patients experiencing symptoms such as:
Burning, stinging, or gritty eyes
Red or irritated eyelids
Fluctuating vision
Watery eyes despite feeling dry
Meibomian gland dysfunction
Dry eye associated with ocular rosacea
Symptoms that keep returning despite artificial tears
Treatment recommendations depend on your individual examination and the factors contributing to your dry eye.
Healthy blinking plays an important role in keeping the ocular surface lubricated. Every complete blink helps spread tears across the eye and supports the release of oils from the meibomian glands.
OptiLift uses Dynamic Muscle Stimulation technology to target the muscles around the eyes. It may be particularly useful when lower eyelid laxity or incomplete blinking is contributing to tear-film instability.
For some Mendham patients, combining OptiLight and OptiLift can address more than one component of dry eye. OptiLight focuses on inflammation and meibomian gland function, while OptiLift can support better eyelid function and blinking.
Amniotic membrane therapy serves a different purpose. Instead of primarily targeting eyelid or gland dysfunction, these biological tissues are used to support healing when the corneal surface itself needs additional help.
Morris Eye Associates uses cryopreserved amniotic membranes such as Prokera and CAM360. Amniotic membrane contains biological properties that can help create an environment that reduces inflammation and supports ocular surface repair.
This type of therapy may be considered when dry eye has progressed to more significant corneal involvement or when the ocular surface is not healing adequately with conventional treatment.
Depending on the condition, an amniotic membrane may remain on the eye temporarily while the cornea heals. Your doctor will monitor the eye and determine how long treatment is needed.
There is no single treatment that is better for every patient.
Someone with meibomian gland dysfunction and inflammation may benefit from OptiLight. A patient whose dry eye is complicated by poor blinking or lower lid laxity may benefit from adding OptiLift. Amniotic membrane therapy may be more appropriate when the corneal surface has become significantly irritated or damaged and needs help healing.
In some cases, these treatments may be used at different stages of the same personalized dry eye plan rather than as competing options.
The most important step is identifying what is driving your symptoms. Dry eye can involve tear evaporation, inflammation, meibomian gland dysfunction, eyelid problems, poor blinking, corneal damage, or several factors at once.
If basic eye drops are no longer providing enough relief, schedule an advanced dry eye evaluation with Morris Eye Associates at 106B East Main St., Mendham, NJ 07945 by calling (862) 222-3800. We can evaluate your tear film, eyelids, glands, and ocular surface to determine whether OptiLight, OptiLift, amniotic membrane therapy, or a personalized combination of treatments is appropriate for your eyes.